Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06507943 · ClinicalTrials.gov registry record · NA

Community Health Equity Accelerator (CHEA) Pediatric Asthma Intervention

A NA study of Asthma in Children, sponsored by Yale University.

Active
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06507943 is a NA study of Asthma in Children that is active but no longer recruiting, run by Yale University. The registered enrollment target is 50 participants, below the 204-participant average among 44 other Asthma in Children trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06507943, a NA study of Asthma in Children, is active but no longer recruiting, sponsored by Yale University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this pilot is to initiate an academic-community partnership and launch a multi-level intervention that includes an asthma exposure pathway (an online decision support and resource) and a health Promotora program that will provide culturally responsive asthma support alongside legal and medical services to improve access to asthma care and ultimately improve asthma-related outcomes in the New Haven region.

Conditions Studied

Interventions

  • BEHAVIORAL Promotora Home Visit

Study Locations (1)

Connecticut

  • Yale - New Haven

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-09-16
Est. Completion 2027-12-31
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT06507943

The ClinicalTrials.gov registry entry for NCT06507943 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 204-participant average among 44 other Asthma in Children trials with a reported enrollment target (75% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma in Children appearing as the primary indexed condition, and to 1 intervention - of which Promotora Home Visit is the first listed.

NCT06507943 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT06507943 about?

NCT06507943 is a clinical study titled "Community Health Equity Accelerator (CHEA) Pediatric Asthma Intervention". The purpose of this pilot is to initiate an academic-community partnership and launch a multi-level intervention that includes an asthma exposure pathway (an online decision support and resource) and a health Promotora program that will provide culturally responsive asthma support alongside legal an...

What is the current status of trial NCT06507943?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-09-16. Estimated completion is 2027-12-31.

What conditions does trial NCT06507943 study?

This clinical trial studies the following conditions: Asthma in Children.

What interventions are being tested in trial NCT06507943?

The interventions under investigation include: Promotora Home Visit (BEHAVIORAL).

Who is sponsoring clinical trial NCT06507943?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06507943 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma in Children

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.